Financial Daily from THE HINDU group of publications
Thursday, Oct 23, 2003
Financial Daily from THE HINDU group of publications Thursday, Oct 23, 2003 |
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures Marketing - Strategy Dabur's UK arm inks pact with Abbott of US Our Bureau
New Delhi , Oct. 22 IN a day of announcements of tie-ups between domestic pharma companies and their foreign counterparts, Dabur India Ltd today said that its UK-based subsidiary had entered into an exclusive strategic alliance, in the cancer segment, with the US-based Abbott Laboratories. Abbott Laboratories is a global major in the US injectibles pharma segment and its alliance with Dabur Oncology Plc is to market the finished dosage forms of Dabur's product in the US market, a company communiqué issued here today said. The alliance would largely span the development, manufacture and marketing of prescription generic oncology products in the US. Further, the company pointed out that a joint management committee comprising members from both the companies would be formed to manage the alliance. Global estimates put the value of oncology products losing patent protection by 2010 at over $15 billion. Accenture, appointed by Dabur Pharma in developing and executing its strategy for the pharma segment, assisted Dabur in this deal, the company said. Dabur Pharma has a dosage manufacturing facility in Bordon, UK and an Active Pharmaceutical Ingredients (API) manufacturing facility in Kolkata.
Article E-Mail :: Comment :: Syndication
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |
Copyright © 2003, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|